Skip to main content
. Author manuscript; available in PMC: 2011 Jan 10.
Published in final edited form as: Leuk Lymphoma. 2010 Aug;51(8):1523–1529. doi: 10.3109/10428194.2010.491137

Figure 1. Treatment Schema.

Figure 1

Additional cycles do not begin until ANC is ≥ 1,000/μL and platelet count is ≥ 50,000/μL. Day 8 Gemcitabine given at 75% of full dose if ANC is between 500 – 1,000/μL or platelet count is between 50,000 – 100,000/μL; if ANC is < 500 or platelets are < 50,000, day 8 gemcitabine is not given. Day 8 rituximab* is given regardless of ANC or platelet count. *for CD20 positive lymphomas